Cartesian Therapeutics (1S70.STU) Q2 2026 Earnings

30AprConfirmed
Q1 2026
Q2 2026
-2.98
-2.23
-1.48
-0.73

Details

Expected EPS
-0.7413092324999999
Actual EPS
-1.2443579999999999
Surprise EPS
-0.5
Surprise Percent
+67.86%

Description

Cartesian Therapeutics (1S70.STU) has reported earnings of -1.2443579999999999 per share for Q2 2026.

0 Comments

Share your thoughts